Couple more days left in November. Expecting the update to be released this week around:
- any feedback from "operator training" at Liverpool's biomedical engineering department
- receipt of administrative "green light" to commence scanning
- See video below giving a clear information of what are next steps in clinical trails some update, e.g. independent ethics committee , role to review trail and highest ethics standards are applied, they need to salsify benefits outweigh the risk.
Some more information on the team I think that are behind the clinical trails at Liverpool (correct me if I'm wrong). CEO is Darryl Harkness https://www.linkedin.com/in/darryl-harkness-5393945/
https://inghaminstitute.org.au/clinical-trials-2/
Couple more days left in November. Expecting the update to be...
Add EMV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.14 |
Change
0.120(5.94%) |
Mkt cap ! $183.0M | |||
| Open | High | Low | Value | Volume |
| $2.05 | $2.14 | $2.05 | $80.72K | 39.02K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2500 | $2.04 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.15 | 14500 | 2 |
View Market Depth
| Last trade - 15.57pm 13/09/2024 (20 minute delay) ? |
| EMV (ASX) Chart |